Stocks and Investing
Stocks and Investing
Mon, March 20, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sat, March 18, 2023
[ 12:00 AM ] - United States, WOPRAI
Fri, March 17, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jacob Johnson Maintained (BLFS) at Buy with Decreased Target to $27 on, Mar 17th, 2023
Jacob Johnson of Stephens & Co., Maintained "BioLife Solutions, Inc." (BLFS) at Buy with Decreased Target from $31 to $27 on, Mar 17th, 2023.
Jacob has made no other calls on BLFS in the last 4 months.
There is 1 other peer that has a rating on BLFS. Out of the 1 peers that are also analyzing BLFS, 0 agree with Jacob's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jacob
- Suraj Kalia of "Oppenheimer" Reiterated at Buy and Held Target at $28 on, Monday, March 6th, 2023
Contributing Sources